| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Esen Saka Topçuoğlu, Ümit Özgür Akdemir, Lütfiye Özlem Ata. What is New in Nuclear Medicine Imaging for Dementia. Noro psikiyatri arsivi. vol 59. issue Suppl 1. 2022-12-29. PMID:36578980. |
amyloid positron emission tomography (pet) and tau pet, which are molecular imaging methods, [f18]fluorodeoxyglucose (fdg) pet showing the glucose metabolism pattern in the brain, dopamine transporter single photon emission computerized tomography (spect) that marks dopaminergic terminals are valuable tools for early recognition and differentiation of ad and its atypical variants, frontotemporal dementias and dementia with lewy bodies. |
2022-12-29 |
2023-08-14 |
Not clear |
| Xing-Jie Xu, Tao Pan, Hui-Jie Fan, Xu Wang, Jie-Zhong Yu, Hai-Fei Zhang, Bao-Guo Xiao, Zhen-Yu Li, Bo Zhang, Cun-Gen Ma, Zhi Cha. Neuroprotective effect of hyperoside in MPP Metabolic brain disease. 2022-12-28. PMID:36576692. |
neuroprotective effect of hyperoside in mpp parkinson's disease (pd) is a neurodegenerative disease characterized by the pathological loss of nigrostriatal dopaminergic neurons, which causes an insufficient release of dopamine (da) and then induces motor and nonmotor symptoms. |
2022-12-28 |
2023-08-14 |
Not clear |
| Tahereh Ghaedian, Ali Razmkon, Leila Kalhor, Vahid Reza Ostovan, Omid Yousefi, Raziyeh Rezaei, Mohammad Reza Hossein-Tehrani, Abbas Rakhsh. Correlation of response to subthalamic deep brain stimulation in Parkinson's disease patients with striatal dopamine transporter density on 99mtc-TRODAT-1 SPECT. Neurological research. 2022-12-27. PMID:36573915. |
since the loss of dopaminergic neurons in the substantia nigra is the main pathophysiology of pd, we aimed to evaluate the association of response to dbs with preoperative dopamine transporter density (dat) and its postoperative changes in pd patients who underwent the bilateral implantation of the electrodes in the subthalamic nucleus (stn). |
2022-12-27 |
2023-08-14 |
Not clear |
| Dmitry Troshev, Victor Blokhin, Valeria Ukrainskaya, Anna Kolacheva, Michael Ugrumo. Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research. Frontiers in molecular neuroscience. vol 15. 2022-12-26. PMID:36568278. |
isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research. |
2022-12-26 |
2023-08-14 |
mouse |
| Dmitry Troshev, Victor Blokhin, Valeria Ukrainskaya, Anna Kolacheva, Michael Ugrumo. Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research. Frontiers in molecular neuroscience. vol 15. 2022-12-26. PMID:36568278. |
we have developed a method for selecting a population of dns from the sn of mice, as evidenced by: (i) immunopositivity of 95% of the sorted cells for tyrosine hydroxylase, the first enzyme of dopamine synthesis; (ii) the sorted cells expressing the genes for specific proteins of the dopaminergic phenotype, tyrosine hydroxylase, the dopamine transporter, and vesicular monoamine transporter 2 and non-specific proteins, such as aromatic l-amino acid decarboxylase, non-specific enzyme of dopamine synthesis. |
2022-12-26 |
2023-08-14 |
mouse |
| Dewei Ye, Jiating Huang, Jiaming Wu, Kang Xie, Xiang Gao, Kaixuan Yan, Pengfei Zhang, Ying Tao, Yun Li, Shufei Zang, Xianglu Rong, Jun Li, Jiao Gu. Integrative metagenomic and metabolomic analyses reveal gut microbiota-derived multiple hits connected to development of gestational diabetes mellitus in humans. Gut microbes. vol 15. issue 1. 2022-12-23. PMID:36550785. |
blood metabolite profiles revealed that gdm patients exhibited a marked increase in 2-hydroxybutyric acid and l-alpha-aminobutyric acid, but a decrease in methionine sulfoxide, allantoin, and dopamine and dopaminergic synapse, when compared with those in ngt controls. |
2022-12-23 |
2023-08-14 |
Not clear |
| Giselle Prunell, Silvia Olivera-Brav. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology. Biomolecules. vol 12. issue 12. 2022-12-23. PMID:36551173. |
parkinson's disease (pd) is an incurable neurodegenerative disease of high prevalence, characterized by the prominent death of dopaminergic neurons in the substantia nigra pars compacta, which produces dopamine deficiency, leading to classic motor symptoms. |
2022-12-23 |
2023-08-14 |
Not clear |
| Ilya S Zhukov, Anastasia N Vaganova, Ramilya Z Murtazina, Lyubov S Alferova, Elena I Ermolenko, Raul R Gainetdino. Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats. Biomolecules. vol 12. issue 12. 2022-12-23. PMID:36551251. |
additionally, taar9 was co-expressed with genes implicated in dopamine signaling, which may suggest a role for this receptor in the regulation of peripheral dopaminergic transmission. |
2022-12-23 |
2023-08-14 |
rat |
| Juan Carlos Magaña, Cláudia M Deus, Maria Giné-Garriga, Joel Montané, Susana P Pereir. Exercise-Boosted Mitochondrial Remodeling in Parkinson's Disease. Biomedicines. vol 10. issue 12. 2022-12-23. PMID:36551984. |
parkinson's disease (pd) is a movement disorder characterized by the progressive degeneration of dopaminergic neurons resulting in dopamine deficiency in the |
2022-12-23 |
2023-08-14 |
Not clear |
| Jace Jones-Taba. Targeting G protein-coupled receptors in the treatment of Parkinson's disease. Journal of molecular biology. 2022-12-23. PMID:36563742. |
first, we discuss new developments in dopaminergic agents for alleviating pd motor impairment, the role of dopamine receptors in l-dopa induced dyskinesia, as well as agents targeting non-dopamine gpcrs which could augment or replace traditional dopaminergic treatments. |
2022-12-23 |
2023-08-14 |
Not clear |
| Obaydah Abd Alkader Alabrahim, Hassan Mohamed El-Said Azzaz. Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease. Nanoscale advances. vol 4. issue 24. 2022-12-21. PMID:36540116. |
the continuous loss of dopaminergic neurons and the concomitant brain depletion of dopamine levels represent the hallmarks of pd. |
2022-12-21 |
2023-08-14 |
Not clear |
| Changcheng Lu, Shuhui Qu, Zhangfeng Zhong, Hua Luo, Si San Lei, Hai-Jing Zhong, Huanxing Su, Yitao Wang, Cheong-Meng Chon. The effects of bioactive components from the rhizome of Frontiers in pharmacology. vol 13. 2022-12-19. PMID:36532787. |
pd drugs mainly enhance dopamine levels but cannot prevent or slow down the loss of dopaminergic neurons. |
2022-12-19 |
2023-08-14 |
Not clear |
| Yara T Mohamed, Abeer Salama, Mostafa A Rabie, Mai A Abd El Fatta. Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade. International immunopharmacology. vol 114. 2022-12-17. PMID:36527875. |
furthermore, secukinumab increased striatal tyrosine hydroxylase immunoexpression, the rate limiting step in dopamine biosynthesis, to guard against dopaminergic neuronal loss. |
2022-12-17 |
2023-08-14 |
rat |
| Zamira M Muruzheva, Daniil S Egorov, Margarita T Absalyamova, Dmitrii S Traktirov, Marina N Karpenko, Serguei O Fetisso. Neurotensin-Binding Immunoglobulin G in Patients with Parkinson's Disease. Neuroimmunomodulation. 2022-12-14. PMID:36516809. |
neurotensin (nts) is a 13-amino acid neuropeptide functionally linked with the brain dopaminergic system via expression of the nts peptide or its receptor in dopamine neurons. |
2022-12-14 |
2023-08-14 |
Not clear |
| Ciara Frances Pugh, Brian Thomas DeVree, Solveig Gaarde Schmidt, Claus Juul Lolan. Pharmacological Characterization of Purified Full-Length Dopamine Transporter from Cells. vol 11. issue 23. 2022-12-11. PMID:36497070. |
pharmacological characterization of purified full-length dopamine transporter from the dopamine transporter (dat) is a member of the neurotransmitter:sodium symporter (nss) family, mediating the sodium-driven reuptake of dopamine from the extracellular space thereby terminating dopaminergic neurotransmission. |
2022-12-11 |
2023-08-14 |
Not clear |
| Tatiana Pronina, Ekaterina Pavlova, Liliya Dil'mukhametova, Michael Ugrumo. Development of the Periventricular Nucleus as a Brain Center, Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36499006. |
development of the periventricular nucleus as a brain center, containing dopaminergic neurons and neurons expressing individual enzymes of dopamine synthesis. |
2022-12-11 |
2023-08-14 |
rat |
| Tatiana Pronina, Ekaterina Pavlova, Liliya Dil'mukhametova, Michael Ugrumo. Development of the Periventricular Nucleus as a Brain Center, Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36499006. |
we have recently shown that the periventricular nucleus (pevn) of adult rats is a "mixed dopaminergic (daergic) center" containing three thousand neurons: daergic neurons and those expressing one of the dopamine (da)-synthesizing enzymes. |
2022-12-11 |
2023-08-14 |
rat |
| Anastasiia Kotliarova, Alexandra V Podturkina, Alla V Pavlova, Daria S Gorina, Anastasiya V Lastovka, Oleg V Ardashov, Artem D Rogachev, Arseniy E Izyurov, Alla B Arefieva, Alexander V Kulikov, Tatyana G Tolstikova, Konstantin P Volcho, Nariman F Salakhutdinov, Yulia Sidorov. A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity Molecules (Basel, Switzerland). vol 27. issue 23. 2022-12-11. PMID:36500381. |
a newly identified monoterpenoid-based small molecule able to support the survival of primary cultured dopamine neurons and alleviate mptp-induced toxicity parkinson's disease (pd) is the most common age-related movement disorder characterized by the progressive loss of nigrostriatal dopaminergic neurons. |
2022-12-11 |
2023-08-14 |
Not clear |
| Lidia Bellés, Chloé Arrondeau, Ginna Urueña-Méndez, Nathalie Ginovar. Concurrent measures of impulsive action and choice are partially related and differentially modulated by dopamine D Pharmacology, biochemistry, and behavior. vol 222. 2022-12-09. PMID:36473517. |
concurrent measures of impulsive action and choice are partially related and differentially modulated by dopamine d impulsivity is a multidimensional construct, but the relationships between its constructs and their respective underlying dopaminergic underpinnings in the general population remain unclear. |
2022-12-09 |
2023-08-14 |
rat |
| Maeri Yamamoto, Toshiya Inad. Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder. Japanese journal of radiology. 2022-12-08. PMID:36480104. |
several previous pet studies on the central dopaminergic transmission-related ligands in patients with adhd have shown altered binding of dopamine markers in the basal ganglia. |
2022-12-08 |
2023-08-14 |
Not clear |